Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the largest deal in two decades for the medtech company with a large Minnesota ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-01-15 08:57:00















